Stock Information

Stock Quote & Chart

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Historical Price Lookup

Week of December 5, 2022

Date Requested Open Price Day High Day Low Closing Price Volume Split Adjustment Factor
December 5, 2022 $50.38 $50.73 $48.41 $49.38 1,013,029 1:1

NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. The closing price above is not necessarily indicative of future price performance.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investment Calculator

Initial Investment on Nov 09, 2017
Original Shares:
1,000.00
Original Value:
$14,030.00
Current Shares:
1,000.00
Current Value:
$47,345.00
Current Price:
$47.34
Split Adjustment:
1
237.46% Return

Return calculations do not include reinvested cash dividends.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Analyst Coverage

Firm Analyst
Baird
Colleen Kusy
BofA Global Research
Tazeen Ahmad
Citigroup Inc
Yigal Nochomovitz Ph.D.
Cowen and Company
Philip Nadeau Ph.D.
Credit Suisse
Tiago Fauth
Evercore ISI
Umer Raffat
Goldman Sachs
Madhu Kumar
H.C. Wainwright
Douglas Tsao
Jefferies
Christopher Howerton
J.P. Morgan
Anupam Rama
Needham & Co.
Joey Stringer
Oppenheimer & Co. Inc.
Justin Kim
Raymond James
Steven Seedhouse
Roth Capital Partners, L.L.C.
Elemer Piros
Stifel
Annabel Samimy
UBS
Eliana Merle
Wedbush
Laura Chico
Wells Fargo
Derek Archila

Apellis Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Apellis Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Apellis Pharmaceuticals, Inc. or its management. Apellis Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.